Russell Investments Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-78
| Closed | -$7.95K | – | 3663 |
|
|
2023
Q2 | $7.95K | Sell |
78
-46
| -37% | -$4.69K | ﹤0.01% | 3014 |
|
|
2023
Q1 | $11.3K | Sell |
124
-6,018
| -98% | -$547K | ﹤0.01% | 2868 |
|
|
2022
Q4 | $233K | Buy |
6,142
+994
| +19% | +$37.8K | ﹤0.01% | 2533 |
|
|
2022
Q3 | $129K | Buy |
+5,148
| New | +$129K | ﹤0.01% | 2627 |
|
|
2022
Q1 | – | Sell |
-42,089
| Closed | -$1.11M | – | 2995 |
|
|
2021
Q4 | $1.11M | Buy |
42,089
+874
| +2% | +$23K | ﹤0.01% | 2099 |
|
|
2021
Q3 | $4.15M | Buy |
41,215
+5,898
| +17% | +$593K | 0.01% | 1358 |
|
|
2021
Q2 | $5M | Buy |
+35,317
| New | +$5M | 0.01% | 1350 |
|
|
2020
Q3 | – | Sell |
-5,787
| Closed | -$902K | – | 3278 |
|
|
2020
Q2 | $902K | Buy |
5,787
+4,264
| +280% | +$665K | ﹤0.01% | 2117 |
|
|
2020
Q1 | $219K | Sell |
1,523
-3,663
| -71% | -$527K | ﹤0.01% | 2518 |
|
|
2019
Q4 | $1.06M | Buy |
5,186
+2,689
| +108% | +$550K | ﹤0.01% | 2068 |
|
|
2019
Q3 | $200K | Buy |
+2,497
| New | +$200K | ﹤0.01% | 2612 |
|
|
2017
Q3 | – | Sell |
-8,012
| Closed | -$254K | – | 3022 |
|
|
2017
Q2 | $254K | Buy |
+8,012
| New | +$254K | ﹤0.01% | 2635 |
|